Complementary and Alternative Medicine(CAM) Use in Pediatric Disease: A Short Review

Authors

1 Students Research Committee, Faculty of Traditional Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

2 Pediatrics Gastroenterology flow, Department of Pediatrics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

3 Department of Pediatrics Gastroenterology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Abstract

CAM therapies have become increasingly  popular in pediatric populations. phytotherapy are the most common CAM used in children. Yet, little is known about children’s preferences for CAM. But It is expected to become more widely integrated into the modern medical system, including the medical curriculum.The aim of this study is to introduce the prevalence and characteristics of CAM use in Pediatrics disease. Further research is warranted to examine the safety and effectiveness of this popular non-allopathic approach to children’s  health.

Keywords


Introduction

Complementary and Alternative Medicine (CAM) is defined as “a group of diverse medical and health care systems, practices, and products that are not generally considered to be part of conventional medicine” (1).

The American Academy of Pediatrics Provisional Section of Complementary, Holistic, and Integrative Medicine, the Task Force on Complementary and Alternative Medicine, stated:“Pediatricians and other clinicians who care for children have the responsibility to advise and counsel patients and families about relevant, safe, effective, and age-appropriate health services and therapies regardless of whether they are considered mainstream or CAM” (2).

Utilizing data from 2007 National Health Interview Survey (NHIS), Barnes et al recently estimated that 11.8% of children in the U.S. use CAM (3).

This report highlighted the most frequent CAM therapies used among children: biologically based therapies (4.7%), mind- body therapies (4.3%), and manipulative and body-based therapies (3.7%).

In East Asia, the use of CAM is influenced  by both culture and local heath care

 

systems. The Italian Society of Pediatrics established a working-party for CAM (4). Among pediatric populations, CAM interventions such as homeopathy, naturopathy, acupuncture, chiropractic, herbal supplements, vitamin and mineral supplementation, macrobiotics and dietary modifications are reportedly used by 2% to 20–30% of patients (5-7). Higher rates have been reported among children with specific medical conditions, such as pediatric cancer, rheumatoid arthritis and cystic fibrosis, where 30–70% of patients employ CAM therapies (8,9)

 

Complementary & alternative therapies with gastrointestinal complaints:

Approximately 36–41% of children with gastrointestinal complaints use comple- mentary and alternative medicine (CAM) each year (10-12). Several herbal preparations, including herbal medications, ginger, monoextract and peppermint oil have been employed for the treatment of Functional gastrointestinal disorders (FGIDs).

Nausea/Vomiting:

  • § Herbs :Ginger, Peppermint, Fennel
  • § Chamomile Compresses
  • § Aromatherapy: Citrus (Bergamont, Citrus Mixtures)
  • § Acupressure :P-6 Point (Acupressure bands)

 

Constipation in children:

Constipation is a very common presen- tation, both in primary and secondary care. Prevalence of functional constipation in children ranges from 4-36%.

 

Senna:

Sondheimer et al found that mineral oil (compared to senna) was more likely to reduce the frequency of soiling and recurrence of symptoms of constipation.  Perkin found that lactulose was significantly more likely to give greater number of days of normal stool motions compared to senna (13).Berg compared senna to placebo and found no significant differences in the may be better tolerated, PEG may be more effective. Sondheimer in a non-blinded study showed mineral oil to be superior to Senna in reducing constipation recurrences when used over 3 months (14). More evidence is needed to assess the role of Senna in treating constipation children.

 

Pediatric Diabetes:

The most common CAM therapies reported: vitamins and minerals, herbal therapies and dietary supplements.

 

Chronic Pain:

Over 60% of patients elected to try at least one CAM approach for pain. The most popular CAM therapies were biofeedback, yoga and hypnosis; the least popular were art therapy and energy healing, with craniosacral, acupuncture and massage being intermediate. In the general U.S. adult population, chronic pain is one of the main conditions for which CAM is used (15-17).

Several reports indicate increased prevalence of CAM use among pediatric patients with cancer (31–73%) (18), juvenile rheumatoid arthritis (70%) (19) and cystic fibrosis (66%) (20). A recent study found that children with chronic illnesses (i.e. cancer, cerebral palsy and inflammatory bowel disease) were three times more likely to use CAM than healthy children (21). In many of these chronic conditions, pain may be a significant problem.Despite the high prevalence of CAM use in children with chronic illnesses, little is known regarding patient preferences for specific CAM therapies.

 

Pediatric Patients with Inflammatory Bowel Disease:

Practitioners should know that half of their pediatric patients with Inflammatory Bowel Disease (IBD) may be using CAM in conjunction with or as an alternative to other treatments and that certain predictors can help identify those using CAM therapies.Inflammatory bowel disease is a chronic and relapsing condition characterized by inflammatory infiltrates in the gastrointestinal tract, often requiring repeated exposures to steroids and other immunomodulators and frequent invasive procedures (22,23). Conventional therapies are associated with significant adverse effects, especially corticosteroids with their common side effects and negative impact on the growing and developing child and adolescent. Considering these factors, coupled with a rising interest in alternative therapies, it is not surprising that the use of complementary and alternative medicine (CAM) in chronic pediatric illnesses is reported to be as high as 30% to 70% (24,25). Numerous studies have evaluated the use of CAM in the adult IBD population (26-28); however, the information on CAM in the pediatric population, most of which comes from countries other than the United States, is limited. Published national and international pediatric studies report a wide range of use: 7% to 72% of this population have used CAM therapy or seen an alternative medicine practitioner (29,30). The most common types of CAM used were identified as nutritional supplements, followed by special diets (milk-/dairy-free, low carbohydrates, gluten-free), and only a small percentage used herbal remedies (5.1%).

 

Herbal Medicine in the Treatment of Attention Deficit Hyperactivity Disorder:

Attention Deficit/Hyperactivity Disorder Attention Deficit Hyperactivity Disorder (ADHD) is a commonly diagnosed childhood disorder that affects approximately 3 to 7% of children. Pharmacotherapy is the most commonly recommended intervention for ADHD and it has been shown to be the optimal treatment option in cases where no other comorbid conditions are present. Complementary and Alternative Medicine is widely used by families of children with ADHD. Herbal medicine is widely used by families of children with ADHD.

Herbal medicines have been shown to ameliorate ADHD related behaviors in individuals without this disorder (31,32). For example, Ginkgo biloba is somewhat effective for dementia and memory impairment. Ginkgo improves cerebro- vascular blood flow and attention and may help to reduce hyperactivity due to boredom and lack of focus (32). However, a recent double blind, randomized and active controlled trial does not support the application of Ginkgo biloba in the treatment of ADHD (33). A study by Akhondzadeh et al, showed that Passiflora incarnata may be a novel therapeutic agent for the treatment of attention deficit hyperactivity disorder.

 

Complementary and Alternative Medicine Pediatric Oncology:

The use of complementary and alternative medicine (CAM) in conjunction with standard medical treatment is an emerging integrative approach in the care of oncology patients (34). Among pediatric oncology patients, CAM mind–body interventions are most often used as supportive care therapies to relieve symptoms, reduce side effects of treatment, and cope with the emotional aspect of living with a life-threatening disease (35). The interventions include hypnosis for reducing pain, anxiety, nausea, or vomiting (35) and music therapy and massage for improving mood states, anxiety, and symptom distress (36). With the increased use of CAM among pediatric oncology patients, investigations about its prevalence, safety, and effectiveness have emerged. Bishop and colleagues conducted a systematic review of published studies from 1975 to 2005, which included 28 studies with survey data to summarize the current evidence on the prevalence of CAM among children with cancer (37 ). The total sample size across all 28 studies included 3526 pediatric oncology patients in whom the prevalence of CAM usage ranged from 6% to 91%. In contrast to what was reported by Post-White,57 Bishop and colleagues reported that herbal remedies were the most often reported CAM modality used for these children, followed by diets/nutrition and faith healing (37).

 

Palliative Care:

  • Alternative medical systems: acupuncture.
  • Mind-body medicine: Meditation, prayer, music therapy.
  • Body-based therapies: Massage.
  • Energy therapies: Reiki, Therapeutic touch.

Conclusion:

CAM includes techniques such as acupuncture, chiropractics, homeopathy, herbal medicine and spiritual healing. It is important for clinicians to be aware of some of the more common forms of CAM, especially since some therapies can have adverse effects and may interfere with conventional, allopathic medications. evidence to support the use of CAM modalities in children is lacking, and there is a serious need for further research in this area.

  • Children are using CAM therapies.
  • Physicians need to inquire about CAM use.
  • Biologically active therapies including herbs and dietary supplements are often used.
  • Adverse effects and especially interactions with conventional drugs are possible.
  • CAM therapies may be especially useful for symptom management.


*Corresponding Author:

Ph.d Student, Faculty of Traditional Medicine, Mashhad University of Medical Science, Iran.    

E-mail: norasmt901@mums.ac.ir

Received:Oct 12,2013; Accepted:Oct 29, 2013

1. What is CAM? National Center for Complementary and Alternative Medicine. National Institute of Health; National Center for Complementary and Alternative Medicine, National Institute of Health.

2. Kemper KJ, Vohra S, Walls R. American Academy of Pediatrics. The use of complementary and alternative medicine in pediatrics. Pediatrics 2008;122(6):1374–1386.

3. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 2009;(12):1–23.

4.Salvioli GP. I pediatri Italiani e le medicine complementari. Pediatria 2011,1:4–5.

5. Davis MP, Darden PM. Use of complementary and alternative medicine by children in the United States. Arch Pediatr Adolesc Med 2003;157:393–6.

6. Ottolini MC, Hamburger EK, Loprieato JO, Coleman RH,Sachs HC, Madden R, et al. Complementary and alternative medicine use among children in the Washington, DC area. Ambul Pediatr 2001;1:122–5.

7. Simpson N, Pearce A, Finlay F, Lenton S. The use of complementary medicine in paediatric outpatient clinics. Ambul Child Health 1998;3:351–6.

8. Grootenhuis MA, Last BF, de Graaf-Nijkerk JH, van der Wel M.Use of alternative treatment in pediatric oncology. Cancer Nurs 1998;21:282–8.

9. Stern RC, Canda ER, Doershuk CF. Use of nonmedical treatment by cystic fibrosis patients. J Adolesc Health 1992;13:612–5.

10. Vlieger AM, Blink M, Tromp E, Benninga MA. Use of complementary and alternative medicine by pediatric patients with functional and organic gastrointestinal diseases: results from a multicenter survey. Pediatrics 2008;122(2):e446–e451.

11. Day AS. Use of complementary and alternative therapies and probiotic agents by children attending gastroenterology outpatient clinics. J Paediatr Child Health 2002;38(4):343–346.

12. Heuschkel R, Afzal N, Wuerth A, Zurakowski D, Leichtner A, Kemper K, et al. Complementary medicine use in children and young adults with inflammatory bowel disease. Am J Gastroenterol 2002;97(2):382–388.

13. Perkin JM: Constipation in childhood: a controlled comparison between lactulose and standardized senna. Curr Med Res Opin 1977, 4:540-543.

14. Sondheimer JM, Gervaise EP: Lubricant versus laxative in the treatment of chronic functional constipation of children: a comparative study. JPediatr Gastroenterol Nutr 1982, 1:223-226.

15. Astin JA. Why patients use alternative medicine: results of a national study. JAMA 1998;279:154853.

16. Bausell RB, Lee W, Berman BM. Demographic and health-related correlates of visits to complementary and alternative medical providers. Med Care 2001;39:190–196.

17. Eisenbeg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990–1997. JAMA 1998;280:1569–75.

18. Grootenhuis MA, Last BF, de Graaf-Nijkerk JH, van der Wel M. Use of alternative treatment in pediatric oncology. Cancer Nurs 1998;21:282–8.

19. Southwood TR, Malleson PN, Roberts-Thomson PJ, Mahy M. Unconventional remedies used for patients with juvenile arthritis. Pediatrics 1990;85:150–4

20. Stern RC, Canda ER, Doershuk CF. Use of nonmedical treatment by cystic fibrosis patients. J Adolesc Health 1992;13:612–5.

21. McCann LJ, Newell SJ. Survey of paediatric complementary and alternative medicine use in health and chronic illness. Arch Dis Child 2006;91:173–174.

22. Andres PG, Friedman LS. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am 1999; 28:255–81.

23. Heyman MB, Kirschner BS, Gold BD, Ferry G, Baldassano R, Cohen SA, et al. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr 2005; 146:35–40.

24. Fernandez CV, Stutzer CA, MacWilliam L, Fryer C. Alternative and complementary therapy use in pediatric oncology patients in British Columbia: prevalence and reasons for use and nonuse. J Clin Oncol 1998; 16:1279–86.

25. Grootenhuis MA, Last BF, de Graaf-Nijkerk JH, van der Wel M. Use of alternative treatment in pediatric oncology. Cancer Nurs 1998; 21:282–8.

26. Stern RC, Canda ER, Doershuk CF. Use of nonmedical treatment by cystic fibrosis patients. J Adolesc Health 1992; 13:612–5.

27. Barnes, PM, Powell-Griner E, McFann K, Nahin RL. [Accessed May 25, 2008] CDC Advance Data Report No. 343. Complementary and alternative medicine use among adults: United States, 2002.

Centers for Disease Control and Prevention Website. http://nccam.nih.gov/news/report.pdf.

28. Hilsden RJ, Scott CM, Verhoef MJ. Complementary medicine use by patients with inflammatory bowel disease. Am J Gastroenterol 1998; 93:697–701.

29. Day AS, Whitten KE, Bohane TD. Use of complementary and alternative medicines by children and adolescents with inflammatory bowel disease. J Paediatr Child Health 2004; 40:681–4.

30. Heuschkel R, Afzal N, Wuerth A, Zurakowski D, Leichtner A, Kemper K, et al. Complementary medicine use in children and young adults with inflammatory bowel disease. Am J Gastroenterol 2002; 97:382–8.

31. Agha-Hosseini M, Kashani L, Aleyaseen A, Ghoreishi A, Rahmanpour H, Zarrinara AR, et al. Crocus sativus L.(saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial. BJOG 2008; 115:515 - 9.

32. Cala S, Crismon ML, Baumgartner J. A survey of herbal use in children with attention-deficit-hyperactivity disorder or depression. Pharmacotherapy 2003; 23: 222 -30.

33. Salehi B, Imani R, Mohammadi MR, Fallah J, Mohammadi M, Ghanizadeh A,et al. Ginkgo biloba for attentiondeficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial. Prog. Neuropsychopharmacol Biol. Psychiatry 2010; 34: 76 – 80.

34. Post-White J, Sencer S, Fitzgerald M. Complementary and alternative treatments in children with cancer. In: Kelly K, Baggott C, Foley G,editors. Nursing Care of the Child with Cancer. 2nd ed. Philadelphia:Saunders; 2003:256–263.

35. Post-White J, Hawks R. Complementary and alternative medicine in pediatric oncology. Sem Oncol Nurs 2005;21:107–114.

36. Post-White J. Complementary and alternative medicine in pediatric oncology. J Pediatr Oncol Nurs 2006;23:244–253.

37. Bishop FL, Prescott P, Chan YK, Saville J, von Elm E, Lewith GT. Prevalence of complementary medicine use in pediatric cancer: a systematic review. Pediatrics 2010;125:768–776.